Overview Financials News + Filings Key Docs Charts Ownership Insiders |
VINCE HOLDING CORP. (VNCE)
|
Add to portfolio |
|
|
Price: |
$7.85
| | Metrics |
OS: |
12.4
|
M
| |
-6
|
% ROE
|
Market cap: |
$97.2
|
M
| |
7
|
% ROIC
|
Net cash:
|
$422
|
k
| |
$0.03
|
per share
|
EV:
|
$96.7
|
M
| | | |
| | | | | |
TTM Valuation | | | |
EBITDA
|
|
| |
|
|
EBIT
|
$47.6
|
M
| |
2.0
|
x EV/EBIT
|
EPS |
($0.88)
| |
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
In millions, except per share items | Jan-29-22 | Jan-30-21 | Feb-01-20 | Feb-02-19 | Feb-03-18 | Jan-28-17 | Jan-30-16 | Jan-31-15 |
Revenues | 322.7 | 219.9 | 375.2 | 361.7 | 272.6 | 268.2 | 302.5 | 340.4 |
Revenue growth | 46.8% | -41.4% | 3.7% | 32.7% | 1.6% | -11.3% | -11.1% | 18.1% |
Cost of goods sold | 176.1 | 131.3 | 196.8 | 192.3 | 150.8 | 145.4 | 169.9 | 173.6 |
Gross profit | 146.6 | 88.6 | 178.4 | 169.4 | 121.8 | 122.8 | 132.5 | 166.8 |
Gross margin | 45.4% | 40.3% | 47.6% | 46.8% | 44.7% | 45.8% | 43.8% | 49.0% |
Selling, general and administrative | 146.1 | 122.8 | 179.3 | 164.0 | 140.1 | 134.4 | 116.8 | 96.6 |
EBITA | 1.1 | -20.5 | 0.7 | 7.9 | -17.7 | -11.0 | 16.3 | 70.8 |
EBITA margin | 0.4% | -9.3% | 0.2% | 2.2% | -6.5% | -4.1% | 5.4% | 20.8% |
Amortization of intangibles | 0.7 | 0.7 | 1.6 | 2.5 | 0.6 | 0.6 | 0.6 | 0.6 |
EBIT | 0.5 | -21.2 | -0.9 | 5.4 | -18.3 | -11.6 | 15.7 | 70.3 |
EBIT margin | 0.1% | -9.6% | -0.2% | 1.5% | -6.7% | -4.3% | 5.2% | 20.6% |
Pre-tax income | -8.1 | -63.8 | 30.5 | -1.8 | 58.0 | -68.9 | 8.3 | 59.7 |
Income taxes | 4.6 | 1.9 | 0.1 | 0.2 | -0.6 | 93.7 | 3.2 | 24.0 |
Tax rate | | | 0.3% | | | | 38.7% | 40.2% |
Net income | -12.7 | -65.6 | 30.4 | -2.0 | 58.6 | -162.7 | 5.1 | 35.7 |
Net margin | -3.9% | -29.9% | 8.1% | -0.5% | 21.5% | -60.6% | 1.7% | 10.5% |
|
Diluted EPS | ($1.07) | ($5.58) | $2.55 | ($0.17) | $7.70 | ($35.04) | $1.36 | $0.93 |
Shares outstanding (diluted) | 11.9 | 11.8 | 11.9 | 11.6 | 7.6 | 4.6 | 3.8 | 38.2 |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|